FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156818981> ?p ?o ?g. }

• W2156818981 endingPage "577" @default.
• W2156818981 startingPage "567" @default.
• W2156818981 abstract "We analysed incidence, predictors, histological features and specific treatment options of anti-tumour necrosis factor α (TNF-α) antibody-induced psoriasiform skin lesions in patients with inflammatory bowel diseases (IBD).Patients with IBD were prospectively screened for anti-TNF-induced psoriasiform skin lesions. Patients were genotyped for IL23R and IL12B variants. Skin lesions were examined for infiltrating Th1 and Th17 cells. Patients with severe lesions were treated with the anti-interleukin (IL)-12/IL-23 p40 antibody ustekinumab.Among 434 anti-TNF-treated patients with IBD, 21 (4.8%) developed psoriasiform skin lesions. Multiple logistic regression revealed smoking (p=0.007; OR 4.24, 95% CI 1.55 to 13.60) and an increased body mass index (p=0.029; OR 1.12, 95% CI 1.01 to 1.24) as main predictors for these lesions. Nine patients with Crohn's disease and with severe psoriasiform lesions and/or anti-TNF antibody-induced alopecia were successfully treated with the anti-p40-IL-12/IL-23 antibody ustekinumab (response rate 100%). Skin lesions were histologically characterised by infiltrates of IL-17A/IL-22-secreting T helper 17 (Th17) cells and interferon (IFN)-γ-secreting Th1 cells and IFN-α-expressing cells. IL-17A expression was significantly stronger in patients requiring ustekinumab than in patients responding to topical therapy (p=0.001). IL23R genotyping suggests disease-modifying effects of rs11209026 (p.Arg381Gln) and rs7530511 (p.Leu310Pro) in patients requiring ustekinumab.New onset psoriasiform skin lesions develop in nearly 5% of anti-TNF-treated patients with IBD. We identified smoking as a main risk factor for developing these lesions. Anti-TNF-induced psoriasiform skin lesions are characterised by Th17 and Th1 cell infiltrates. The number of IL-17A-expressing T cells correlates with the severity of skin lesions. Anti-IL-12/IL-23 antibody therapy is a highly effective therapy for these lesions." @default.
• W2156818981 created "2016-06-24" @default.
• W2156818981 creator A5011793416 @default.
• W2156818981 creator A5014333518 @default.
• W2156818981 creator A5015714294 @default.
• W2156818981 creator A5021566006 @default.
• W2156818981 creator A5030259246 @default.
• W2156818981 creator A5031764500 @default.
• W2156818981 creator A5033540298 @default.
• W2156818981 creator A5034794115 @default.
• W2156818981 creator A5036055961 @default.
• W2156818981 creator A5051987249 @default.
• W2156818981 creator A5057456576 @default.
• W2156818981 creator A5059052168 @default.
• W2156818981 creator A5064845651 @default.
• W2156818981 creator A5073722593 @default.
• W2156818981 creator A5078839131 @default.
• W2156818981 creator A5081904439 @default.
• W2156818981 creator A5082151552 @default.
• W2156818981 creator A5082823845 @default.
• W2156818981 creator A5085889329 @default.
• W2156818981 creator A5086343499 @default.
• W2156818981 date "2013-03-06" @default.
• W2156818981 modified "2023-10-15" @default.
• W2156818981 title "Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment" @default.
• W2156818981 cites W147965450 @default.
• W2156818981 cites W1482448048 @default.
• W2156818981 cites W1509473864 @default.
• W2156818981 cites W1576903429 @default.
• W2156818981 cites W1833973510 @default.
• W2156818981 cites W1970044643 @default.
• W2156818981 cites W1978171344 @default.
• W2156818981 cites W1979011193 @default.
• W2156818981 cites W1980725116 @default.
• W2156818981 cites W1981383482 @default.
• W2156818981 cites W1981714996 @default.
• W2156818981 cites W1987232881 @default.
• W2156818981 cites W1989581181 @default.
• W2156818981 cites W1991314184 @default.
• W2156818981 cites W2005359518 @default.
• W2156818981 cites W2005553679 @default.
• W2156818981 cites W2007533329 @default.
• W2156818981 cites W2012077729 @default.
• W2156818981 cites W2016499642 @default.
• W2156818981 cites W2018933969 @default.
• W2156818981 cites W2026826896 @default.
• W2156818981 cites W2029292942 @default.
• W2156818981 cites W2033689138 @default.
• W2156818981 cites W2039283137 @default.
• W2156818981 cites W2045113343 @default.
• W2156818981 cites W2050207472 @default.
• W2156818981 cites W2065290004 @default.
• W2156818981 cites W2065637841 @default.
• W2156818981 cites W2066676281 @default.
• W2156818981 cites W2068012094 @default.
• W2156818981 cites W2070339416 @default.
• W2156818981 cites W2075090387 @default.
• W2156818981 cites W2084119784 @default.
• W2156818981 cites W2085127303 @default.
• W2156818981 cites W2091385024 @default.
• W2156818981 cites W2097087846 @default.
• W2156818981 cites W2104201959 @default.
• W2156818981 cites W2105833786 @default.
• W2156818981 cites W2106777223 @default.
• W2156818981 cites W2106779017 @default.
• W2156818981 cites W2110888991 @default.
• W2156818981 cites W2113218931 @default.
• W2156818981 cites W2113628816 @default.
• W2156818981 cites W2116956799 @default.
• W2156818981 cites W2127834887 @default.
• W2156818981 cites W2128377184 @default.
• W2156818981 cites W2130179794 @default.
• W2156818981 cites W2131727319 @default.
• W2156818981 cites W2139008734 @default.
• W2156818981 cites W2141016525 @default.
• W2156818981 cites W2143827807 @default.
• W2156818981 cites W2149566497 @default.
• W2156818981 cites W2149827116 @default.
• W2156818981 cites W2152395469 @default.
• W2156818981 cites W2152507275 @default.
• W2156818981 cites W2155379600 @default.
• W2156818981 cites W2157090771 @default.
• W2156818981 cites W2164617201 @default.
• W2156818981 cites W2168521098 @default.
• W2156818981 cites W2171122944 @default.
• W2156818981 cites W2322390243 @default.
• W2156818981 cites W2561759163 @default.
• W2156818981 cites W4236396577 @default.
• W2156818981 cites W4248269869 @default.
• W2156818981 doi "https://doi.org/10.1136/gutjnl-2012-302853" @default.
• W2156818981 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23468464" @default.
• W2156818981 hasPublicationYear "2013" @default.
• W2156818981 type Work @default.
• W2156818981 sameAs 2156818981 @default.
• W2156818981 citedByCount "247" @default.
• W2156818981 countsByYear W21568189812013 @default.
• W2156818981 countsByYear W21568189812014 @default.
• W2156818981 countsByYear W21568189812015 @default.

• next